Literature DB >> 31434730

Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets.

Mayara F Maggioli1, Maureen H V Fernandes1, Lok R Joshi1, Bishwas Sharma1, Megan M Tweet1, Jessica C G Noll1, Fernando V Bauermann1, Diego G Diel2.   

Abstract

Senecavirus A (SVA) is a picornavirus that causes acute vesicular disease (VD), that is clinically indistinguishable from foot-and-mouth disease (FMD), in pigs. Notably, SVA RNA has been detected in lymphoid tissues of infected animals several weeks following resolution of the clinical disease, suggesting that the virus may persist in select host tissues. Here, we investigated the occurrence of persistent SVA infection and the contribution of stressors (transportation, immunosuppression, or parturition) to acute disease and recrudescence from persistent SVA infection. Our results show that transportation stress leads to a slight increase in disease severity following infection. During persistence, transportation, immunosuppression, and parturition stressors did not lead to overt/recrudescent clinical disease, but intermittent viremia and virus shedding were detected up to day 60 postinfection (p.i.) in all treatment groups following stress stimulation. Notably, real-time PCR and in situ hybridization (ISH) assays confirmed that the tonsil harbors SVA RNA during the persistent phase of infection. Immunofluorescence assays (IFA) specific for double-stranded RNA (dsRNA) demonstrated the presence of double-stranded viral RNA in tonsillar cells. Most importantly, infectious SVA was isolated from the tonsil of two animals on day 60 p.i., confirming the occurrence of carrier animals following SVA infection. These findings were supported by the fact that contact piglets (11/44) born to persistently infected sows were infected by SVA, demonstrating successful transmission of the virus from carrier sows to contact piglets. Results here confirm the establishment of persistent infection by SVA and demonstrate successful transmission of the virus from persistently infected animals.IMPORTANCE Persistent viral infections have significant implications for disease control strategies. Previous studies demonstrated the persistence of SVA RNA in the tonsil of experimentally or naturally infected animals long after resolution of the clinical disease. Here, we showed that SVA establishes persistent infection in SVA-infected animals, with the tonsil serving as one of the sites of virus persistence. Importantly, persistently infected carrier animals shedding SVA in oral and nasal secretions or feces can serve as sources of infection to other susceptible animals, as evidenced by successful transmission of SVA from persistently infected sows to contact piglets. These findings unveil an important aspect of SVA infection biology, suggesting that persistently infected pigs may function as reservoirs for SVA.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  SVA; SVV; Seneca Valley virus; carrier; persistence

Mesh:

Year:  2019        PMID: 31434730      PMCID: PMC6803263          DOI: 10.1128/JVI.00819-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Common threads in persistent viral infections.

Authors:  Melissa Kane; Tatyana Golovkina
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

2.  Pathogenicity and cross-reactive immune responses of a historical and a contemporary Senecavirus A strains in pigs.

Authors:  Maureen H V Fernandes; Mayara F Maggioli; Lok R Joshi; Travis Clement; Tatiane C Faccin; Rolf Rauh; Fernando V Bauermann; Diego G Diel
Journal:  Virology       Date:  2018-07-18       Impact factor: 3.616

3.  Improved techniques for the detection of foot-and-mouth disease virus in carrier cattle.

Authors:  P Sutmoller; G E Cottral
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  Senecavirus A: An Emerging Vesicular Infection in Brazilian Pig Herds.

Authors:  R A Leme; E Zotti; B K Alcântara; M V Oliveira; L A Freitas; A F Alfieri; A A Alfieri
Journal:  Transbound Emerg Dis       Date:  2015-09-23       Impact factor: 5.005

5.  Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.

Authors:  Alexis Bouin; Paul-Antoine Gretteau; Michel Wehbe; Fanny Renois; Yohan N'Guyen; Nicolas Lévêque; Michelle N Vu; Steven Tracy; Nora M Chapman; Patrick Bruneval; Paul Fornes; Bert L Semler; Laurent Andreoletti
Journal:  Circulation       Date:  2019-05-14       Impact factor: 29.690

Review 6.  The persistence of bovine viral diarrhea virus.

Authors:  Kenny V Brock
Journal:  Biologicals       Date:  2003-06       Impact factor: 1.856

7.  Identification and Complete Genome of Seneca Valley Virus in Vesicular Fluid and Sera of Pigs Affected with Idiopathic Vesicular Disease, Brazil.

Authors:  F A Vannucci; D C L Linhares; D E S N Barcellos; H C Lam; J Collins; D Marthaler
Journal:  Transbound Emerg Dis       Date:  2015-09-07       Impact factor: 5.005

8.  A novel RNA-based in situ hybridization to detect Seneca Valley virus in neonatal piglets and sows affected with vesicular disease.

Authors:  Talita P Resende; Douglas G Marthaler; Fabio A Vannucci
Journal:  PLoS One       Date:  2017-04-10       Impact factor: 3.240

9.  Vesicular Disease in 9-Week-Old Pigs Experimentally Infected with Senecavirus A.

Authors:  Nestor Montiel; Alexandra Buckley; Baoqing Guo; Vikas Kulshreshtha; Albert VanGeelen; Hai Hoang; Christopher Rademacher; Kyoung-Jin Yoon; Kelly Lager
Journal:  Emerg Infect Dis       Date:  2016-07       Impact factor: 6.883

10.  Neonatal Mortality, Vesicular Lesions and Lameness Associated with Senecavirus A in a U.S. Sow Farm.

Authors:  P Canning; A Canon; J L Bates; K Gerardy; D C L Linhares; P E Piñeyro; K J Schwartz; K J Yoon; C J Rademacher; D Holtkamp; L Karriker
Journal:  Transbound Emerg Dis       Date:  2016-05-23       Impact factor: 5.005

View more
  7 in total

1.  Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3.

Authors:  Hang Gao; Zhaoying Xiang; Xinna Ge; Lei Zhou; Jun Han; Xin Guo; Yanhong Chen; Yongning Zhang; Hanchun Yang
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

2.  Potent Protective Immune Responses to Senecavirus Induced by Virus-Like Particle Vaccine in Pigs.

Authors:  Suyu Mu; Shiqi Sun; Hu Dong; Manyuan Bai; Yun Zhang; Zhidong Teng; Mei Ren; Shuanghui Yin; Huichen Guo
Journal:  Vaccines (Basel)       Date:  2020-09-15

3.  Infectious dose of Senecavirus A in market weight and neonatal pigs.

Authors:  Alexandra Buckley; Kelly Lager
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

4.  Characterization of Senecavirus A Isolates Collected From the Environment of U.S. Sow Slaughter Plants.

Authors:  Kyle S Hoffman; Nicki L Humphrey; John A Korslund; Tavis K Anderson; Kay S Faaberg; Kelly M Lager; Alexandra C Buckley
Journal:  Front Vet Sci       Date:  2022-06-22

5.  2B and 3C Proteins of Senecavirus A Antagonize the Antiviral Activity of DDX21 via the Caspase-Dependent Degradation of DDX21.

Authors:  Kuan Zhao; Xiao-Ran Guo; Shuai-Feng Liu; Xiao-Na Liu; Ying Han; Lu-Lu Wang; Bai-Shi Lei; Wu-Chao Zhang; Li-Min Li; Wan-Zhe Yuan
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

Review 6.  Structures and Functions of Viral 5' Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections.

Authors:  Marie Glenet; Laetitia Heng; Domitille Callon; Anne-Laure Lebreil; Paul-Antoine Gretteau; Yohan Nguyen; Fatma Berri; Laurent Andreoletti
Journal:  Viruses       Date:  2020-08-21       Impact factor: 5.048

7.  Prolonged Viability of Senecavirus A in Exposed House Flies (Musca domestica).

Authors:  Justin Heath Turner; Willian Pinto Paim; Mayara Fernanda Maggioli; Cristina Mendes Peter; Robert Miknis; Justin Talley; Fernando Vicosa Bauermann
Journal:  Viruses       Date:  2022-01-11       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.